journal article·2024-05-01Open access

Eco-friendly synthesis of mesoporous bioactive glass ceramics and functionalization for drug delivery and hard tissue engineering applications

Sobia Tabassum, Muhammad Saqib, Madeeha Batool, Faiza Sharif, Mazhar Amjad Gilani, Olivier Huck

Biomedical Materials· Volume 19· Issue 3

Abstract

Abstract Hard tissue regenerative mesoporous bioactive glass (MBG) has traditionally been synthesized using costly and toxic alkoxysilane agents and harsh conditions. In this study, MBG was synthesized using the cheaper reagent SiO2 by using a co-precipitation approach. The surface properties of MBG ceramic were tailored by functionalizing with amino and carboxylic groups, aiming to develop an efficient drug delivery system for treating bone infections occurring during or after reconstruction surgeries. The amino groups were introduced through a salinization reaction, while the carboxylate groups were added via a chain elongation reaction. The MBG, MBG-NH2, and MBG-NH-COOH were analyzed by using various techniques: x-ray diffraction (XRD), Fourier transform infrared spectroscopy (FTIR), Brunauer–Emmett–Teller (BET), scanning electron microscopy and energy-dispersive x-ray spectroscopy. The XRD results confirmed the successful preparation of MBG, and the FTIR results indicated successful functionalization. BET analysis revealed that the prepared samples were mesoporous, and functionalization tuned their surface area and surface properties. Cefixime, an antibiotic, was loaded onto MBG, MBG-NH2, and MBG-NH-COOH to test their drug-carrying capacity. Comparatively, MBG-NH-COOH showed good drug loading and sustained release behavior. The release of the drug followed the Fickian diffusion mechanism. All prepared samples displayed favorable biocompatibility at higher concentration in the Alamar blue assay with MC3T3 cells and exhibited the good potential for hard tissue regeneration, as carbonated hydroxyapatite formed on their surfaces in simulated body fluid.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Bone Tissue Engineering Materials · Spine and Intervertebral Disc Pathology · Dental Implant Techniques and Outcomes

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (69)

Show source-provided references
1. Global, regional, and national burden of bone fractures in 204 countries and territories, 1990–2019: a systematic analysis from the Global Burden of Disease Study 201910.1016/S2666-7568(21)00172-0 ↗
2. Mansour · 2020 · 43
3. Efficient drug delivery system for bone repair by tuning the surface of hydroxyapatite particles10.1039/C6RA24551J ↗
4. Role of substitution in bioceramics10.1016/B978-0-08-102834-6.00005-7 ↗
5. Well-ordered mesoporous bioactive glasses (MBG): a promising bioactive drug delivery system10.1016/j.jconrel.2005.11.002 ↗
6. Mesoporous silica-based bioactive glasses for antibiotic-free antibacterial applications10.1016/j.msec.2017.11.003 ↗
7. Bone-targeted biomaterials: strategies and applications10.1016/j.cej.2022.137133 ↗
8. Surface-grafted remedial hydroxyapatite nanoparticles to avoid operational infections10.1007/s00706-018-2339-z ↗
9. Enhanced surface properties of hydroxyapatite by grafting tartaric acid for sustained release of moxifloxacin10.1002/slct.201803398 ↗
10. Bonding mechanisms at the interface of ceramic prosthetic materials10.1002/jbm.820050611 ↗
11. Highly ordered mesoporous bioactive glasses with superior in vitro bone‐forming bioactivities10.1002/anie.200460598 ↗
12. The in-vitro bioactivity of mesoporous bioactive glasses10.1016/j.biomaterials.2006.01.043 ↗
13. Influence of fluoride additions on biological and mechanical properties of Na2O–CaO–SiO2–P2O5 glass–ceramics10.1016/j.msec.2013.10.028 ↗
14. Mechanical characteristic and biological behaviour of implanted and restorative bioglasses used in medicine and dentistry: a systematic review10.1016/j.dental.2017.03.017 ↗
15. Biodegradable mesoporous bioactive glass nanospheres for drug delivery and bone tissue regeneration10.1088/0957-4484/27/22/225102 ↗
16. Functionalized mesoporous bioactive glass scaffolds for enhanced bone tissue regeneration10.1038/s41598-016-0001-8 ↗
17. Development of antibiotic loaded mesoporous bioactive glass and its drug release kinetics10.1016/j.ceramint.2019.10.264 ↗
18. Delivery of dimethyloxallyl glycine in mesoporous bioactive glass scaffolds to improve angiogenesis and osteogenesis of human bone marrow stromal cells10.1016/j.actbio.2013.06.026 ↗
19. Functional mesoporous bioactive glass nanospheres: synthesis, high loading efficiency, controllable delivery of doxorubicin and inhibitory effect on bone cancer cells10.1039/c3tb20275e ↗
20. Functionalized mesoporous bioactive glass scaffolds for enhanced bone tissue regeneration10.1038/srep19361 ↗
21. Effect of aminated mesoporous bioactive glass nanoparticles on the differentiation of dental pulp stem cells10.1371/journal.pone.0150727 ↗
22. Effects of functional groups on the structure, physicochemical and biological properties of mesoporous bioactive glass scaffolds10.1039/C4TB01287A ↗
23. Amino-functionalized mesoporous bioactive glass for drug delivery10.1088/1748-605X/aa645d ↗
24. Bioresorbable antibacterial PCL-PLA-nHA composite membranes for oral and maxillofacial defects10.1002/pc.24899 ↗
25. Surface-grafted remedial hydroxyapatite nanoparticles to avoid operational infections10.1007/s00706-018-2339-z ↗
26. Increase in VEGF secretion from human fibroblast cells by bioactive glass S53P4 to stimulate angiogenesis in bone10.1002/jbm.a.35069 ↗
27. Superior biocompatibility and comparable osteoinductive properties: sodium-reduced fluoride-containing bioactive glass belonging to the CaO–MgO–SiO2 system as a promising alternative to 45S5 bioactive glass10.1016/j.bioactmat.2019.12.005 ↗
28. Effect of partial crystallization on the mechanical properties and cytotoxicity of bioactive glass from the 3CaO10.1016/j.jmbbm.2012.04.024 ↗
29. Production of bioglass® 45S5–polycaprolactone composite scaffolds via salt-leaching10.1016/j.compstruct.2010.01.017 ↗
30. Acute and subchronic inhalation toxicity of tetraethoxysilane (TEOS) in mice10.1007/s002040050069 ↗
31. Acute urinary tract toxicity of tetraethylorthosilicate in rats10.1016/0272-0590(92)90141-4 ↗
32. Toxicity of silicon compounds in semiconductor industries10.1539/joh.40.270 ↗
33. Preparation and characterization of mesoporous bioactive glass from agricultural waste rice husk for targeted anticancer drug delivery10.1016/j.ceramint.2016.11.007 ↗
34. Effect of sintering temperature variations on fabrication of 45S5 bioactive glass-ceramics using rice husk as a source for silica10.1016/j.msec.2015.12.029 ↗
35. Rice husk derived bioactive glass-ceramic as a functional bioceramic: synthesis, characterization and biological testing10.1016/j.jnoncrysol.2015.07.017 ↗
36. Synthesis, characterization, drug loading and in-vitro bioactivity studies of rice husk derived SiO2–P2O5–MgO–CaO–SrO bio-active glasses10.1016/j.jddst.2020.102154 ↗
37. Structure and properties of bio-glass–ceramics containing natural bones10.1016/j.ceramint.2014.12.046 ↗
38. The effect of residual glassy phase in a bioactive glass-ceramic on the formation of its surface apatite layer in vitro10.1007/BF00701242 ↗
39. Bioactive materials for tissue engineering, regeneration and repair10.1023/A:1027414700111 ↗
40. Effect of heat treatment on the properties of SiO2–CaO–MgO–P2O5 bioactive glasses10.1007/s10856-012-4699-y ↗
41. Original implementation of low-temperature SPS for bioactive glass used as a bone biomaterial10.1016/j.jmbbm.2021.104988 ↗
42. Directed self-assembly of functionalized silica nanoparticles on molecular printboards through multivalent supramolecular interactions10.1021/la047982w ↗
43. Controlled surface functionalization of silica nanospheres by covalent conjugation reactions and preparation of high density streptavidin nanoparticles10.1166/jnn.2004.079 ↗
44. Characterization of some bioactive glasses and glass-ceramics prepared by a hydrothermal method10.1007/s12633-016-9461-5 ↗
45. Fabrication and investigation of high-quality glass-ceramic (GC)–polymethyl methacrylate (PMMA) composite for regenerative medicine10.1039/C7RA05188C ↗
46. The role of vapour deposition in the hydrophobization treatment of cellulose fibres using alkyl ketene dimers and alkenyl succinic acid anhydrides10.1016/j.colsurfa.2006.10.059 ↗
47. Progress of porous silicon APTES-functionalization by FTIR investigations10.1016/j.apsusc.2015.01.107 ↗
48. Bioactivity evolution of the surface functionalized bioactive glasses10.1002/jbm.b.33203 ↗
49. COOH-functionalisation of silica particles10.1016/j.apsusc.2011.04.145 ↗
50. Carboxylic modified spherical mesoporous silicas аs drug delivery carriers10.1016/j.ijpharm.2012.07.061 ↗
51. Characterization of hydroxyapatite and carbonated apatite by photo acoustic FTIR spectroscopy10.1023/a:1018570213546 ↗
52. In situ synthesis of mesoporous polyvinyl alcohol/hydroxyapatite composites for better biomedical coating adhesion10.1016/j.apsusc.2015.12.057 ↗
53. Structural study of sol–gel silicate glasses by IR and Raman spectroscopies10.1016/j.jnoncrysol.2009.01.010 ↗
54. Effect of calcium hydroxide on mechanical strength and biological properties of bioactive glass10.1016/j.jmbbm.2016.03.030 ↗
55. Effect of crystallization on apatite‐layer formation of bioactive glass 45S510.1002/(SICI)1097-4636(199604)30:4<509::AID-JBM9>3.0.CO;2-T ↗
56. Preparation and characterization of amine functional nano-hydroxyapatite/chitosan bionanocomposite for bone tissue engineering applications10.1016/j.carbpol.2017.01.100 ↗
57. FTIR absorption–reflection study of biomimetic growth of phosphates on titanium implants10.1016/S0022-2860(00)00623-2 ↗
58. Adsorption pore structure and its fractal characteristics of coals by N2 adsorption/desorption and FESEM image analyses10.1016/j.fuel.2019.116031 ↗
59. In vitro bactericidal and drug release properties of vancomycin-amino surface functionalized bioactive glass nanoparticles10.1016/j.matchemphys.2019.122423 ↗
60. Hyperbranching surface polymerization as a tool for preferential functionalization of the outer surface of mesoporous silica10.1021/cm7021328 ↗
61. Template-free synthesis of mesoporous Mn3O4-Al2O3 catalyst for low temperature selective catalytic reduction of NO with NH310.1016/j.jtice.2018.12.006 ↗
62. Flap necrosis after palatoplasty in patients with cleft palate10.1155/2015/516375 ↗
63. Comparison of cefixime and amoxicillin plus metronidazole in the treatment of chronic periodontitis10.2298/vsp150326133D ↗
64. Determination of pK a values of cefdinir and cefixime by LC and spectrophotometric methods and their analysis in pharmaceutical dosage forms10.1007/s10337-011-2013-7 ↗
65. Efficient and selective removal of cefixime form aqueous solution by a modified bionanocomposite10.1016/j.jece.2017.06.042 ↗
66. Mesoporous bioactive glass nanoparticles doped with magnesium: drug delivery and acellular in vitro bioactivity10.1039/C9RA01133A ↗
67. Mathematical modelling and controlled drug delivery: matrix systems10.2174/1567201052772906 ↗
68. Modeling and comparison of dissolution profiles10.1016/S0928-0987(01)00095-1 ↗
69. A simple equation for description of solute release I. Fickian and non-Fickian release from non-swellable devices in the form of slabs, spheres, cylinders or discs10.1016/0168-3659(87)90034-4 ↗